نتائج البحث - "Sun, Zhuoxin"

العلاقة: Blood Cancer Journal; Rapaport F, Seier K, Neelamraju Y, et al. Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999 [published correction appears in Blood Cancer J. 2023 Jul 6;13(1):103]. Blood Cancer J. 2022;12(9):137. Published 2022 Sep 23. doi:10.1038/s41408-022-00736-z; https://hdl.handle.net/1805/41204Test

الإتاحة: https://doi.org/10.1038/s41408-022-00736-zTest
https://hdl.handle.net/1805/41204Test

View record in BASE

6

دورية أكاديمية

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial

المؤلفون: Kok, Peey Sei, Forde, Patrick M., Hughes, Brett, Sun, Zhuoxin, Brown, Chris, Ramalingam, Suresh, Cook, Alistair, Lesterhuis, Willem Joost, Yip, Sonia, O'Byrne, Ken, Pavlakis, Nick, Brahmer, Julie, Anagnostou, Valsamo, Ford, Kate, Fitzpatrick, Karen, Bricker, Alison, Cummins, Michelle M., Stockler, Martin, Nowak, Anna K.

المصدر: BMJ Open

مصطلحات موضوعية: Chemotherapy, Immunology, Oncology, Respiratory tract tumours

وصف الملف: application/pdf

العلاقة: https://eprints.qut.edu.au/233044/1/111969415.pdfTest; Kok, Peey Sei, Forde, Patrick M., Hughes, Brett, Sun, Zhuoxin, Brown, Chris, Ramalingam, Suresh, Cook, Alistair, Lesterhuis, Willem Joost, Yip, Sonia, O'Byrne, Ken, Pavlakis, Nick, Brahmer, Julie, Anagnostou, Valsamo, Ford, Kate, Fitzpatrick, Karen, Bricker, Alison, Cummins, Michelle M., Stockler, Martin, & Nowak, Anna K. (2022) Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial. BMJ Open, 12(1), Article number: e057663.; https://eprints.qut.edu.au/233044Test/; Centre for Genomics and Personalised Health; Faculty of Health; School of Biomedical Sciences

الإتاحة: https://doi.org/10.1136/bmjopen-2021-057663Test
https://eprints.qut.edu.au/233044Test/

View record in BASE

7

دورية أكاديمية

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

المؤلفون: Ganzel, Chezi, Sun, Zhuoxin, Baslan, Timour, Zhang, Yanming, Gönen, Mithat, Abdel-Wahab, Omar I., Racevskis, Janis, Garrett-Bakelman, Francine, Lowe, Scott W., Fernandez, Hugo F., Ketterling, Rhett, Luger, Selina M., Litzow, Mark, Lazarus, Hillard M., Rowe, Jacob M., Tallman, Martin S., Levine, Ross L., Paietta, Elisabeth

المصدر: Leukemia Research ; volume 123, page 106971 ; ISSN 0145-2126

مصطلحات موضوعية: Cancer Research, Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.leukres.2022.106971Test
https://api.elsevier.com/content/article/PII:S0145212622003472?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0145212622003472?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC

المؤلفون: Varlotto, John M., Wang, Yating, Sun, Zhuoxin, Wakelee, Heather A., Ramalingam, Suresh, Schiller, Joan

المساهمون: National Cancer Institute, Merck, Amgen, Medtronic, Bristol-Myers Squibb, ECOG-ACRIN Cancer Research Group, Eli Lilly and Company, National Institutes of Health, Genentech, AstraZeneca

المصدر: JTO Clinical and Research Reports ; volume 3, issue 3, page 100274 ; ISSN 2666-3643

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

الإتاحة: https://doi.org/10.1016/j.jtocrr.2021.100274Test
https://api.elsevier.com/content/article/PII:S2666364321001338?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666364321001338?httpAccept=text/plainTest

View record in BASE